Clinical Trial Update: Safety and Optimal Neuroprotection of neu2000 in Ischemic Stroke With Endovascular reCanalizion (SONIC) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update on neu2000 for safety and neuroprotection in ischemic stroke patients undergoing endovascular recanalization; current trial stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• neu2000

Snippet

Sponsor: GNT Pharma | Conditions: Ischemic Stroke | Phase 2 | Status: UNKNOWN